Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Hemorrhage Associated With Oral Anticoagulants.
Lindhoff-Last E, Herrmann E, Lindau S, Konstantinides S, Grottke O, Nowak-Goettl U, Lucks J, Zydek B, Heymann CV, Birschmann I, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A. Lindhoff-Last E, et al. Among authors: lucks j. Dtsch Arztebl Int. 2020 May 1;117(18):312-319. doi: 10.3238/arztebl.2020.0312. Dtsch Arztebl Int. 2020. PMID: 32605708 Free PMC article.
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry.
Lindhoff-Last E, Birschmann I, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E; RADOA-Registry Investigators (Reversal Agent use in patients treated with Direct Oral Anticoagulants or vitamin K antagonists Registry). Lindhoff-Last E, et al. Among authors: lucks j. Thromb Haemost. 2022 Apr;122(4):552-559. doi: 10.1055/a-1549-6556. Epub 2021 Sep 29. Thromb Haemost. 2022. PMID: 34256392 Free PMC article.
Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry).
Lindhoff-Last E, Birschmann I, Bidenharn AJ, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E; RADOA-Registry Investigators. Lindhoff-Last E, et al. Among authors: lucks j. Pharmaceuticals (Basel). 2022 Nov 19;15(11):1437. doi: 10.3390/ph15111437. Pharmaceuticals (Basel). 2022. PMID: 36422567 Free PMC article.
Ten Years of the Synthetic Biology Summer Course at Cold Spring Harbor Laboratory.
Haynes KA, Andrews LB, Beisel CL, Chappell J, Cuba Samaniego CE, Dueber JE, Dunlop MJ, Franco E, Lucks JB, Noireaux V, Savage DF, Silver PA, Smanski M, Young E. Haynes KA, et al. Among authors: lucks jb. ACS Synth Biol. 2024 Sep 20;13(9):2635-2642. doi: 10.1021/acssynbio.4c00276. ACS Synth Biol. 2024. PMID: 39300908 Review.
Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnostics.
Jung JK, Dreyer KS, Dray KE, Muldoon JJ, George J, Shirman S, Cabezas MD, D'Aquino AE, Verosloff MS, Seki K, Rybnicky GA, Alam KK, Bagheri N, Jewett MC, Leonard JN, Mangan NM, Lucks JB. Jung JK, et al. Among authors: lucks jb. bioRxiv [Preprint]. 2024 Jul 3:2024.07.03.601853. doi: 10.1101/2024.07.03.601853. bioRxiv. 2024. PMID: 39005318 Free PMC article. Preprint.
Deconstructing synthetic biology across scales: a conceptual approach for training synthetic biologists.
Karim AS, Brown DM, Archuleta CM, Grannan S, Aristilde L, Goyal Y, Leonard JN, Mangan NM, Prindle A, Rocklin GJ, Tyo KJ, Zoloth L, Jewett MC, Calkins S, Kamat NP, Tullman-Ercek D, Lucks JB. Karim AS, et al. Among authors: lucks jb. Nat Commun. 2024 Jun 26;15(1):5425. doi: 10.1038/s41467-024-49626-x. Nat Commun. 2024. PMID: 38926339 Free PMC article. Review.
94 results